Target intelligence / Profile preview

RNA, U6 small nuclear 289, pseudogene (RNU6-289P)

Target: RNU6-289P
Molecular classification: Pseudogene, Small nuclear RNA (snRNA) pseudogene, Non-coding RNA-derived pseudogene

Overview

RNU6-289P is a human pseudogene related to the U6 small nuclear RNA family. U6 snRNA is a noncoding RNA integral to the spliceosome complex, essential for the splicing of pre-mRNA in eukaryotic cells[5][13]. RNU6-289P itself does not produce functional RNA or protein, nor participate in recognized cellular processes. Pseudogenes such as RNU6-289P often arise through retrotransposition or genomic duplication events, resulting in non-functional genomic copies. While some pseudogenes can acquire novel regulatory functions, there is no evidence that RNU6-289P is actively transcribed or relevant in any biological pathway, clinical context, or as a drug target[6][7][10].

Other names: RNU6-289PRNA, U6 small nuclear 289, pseudogene

Mechanism of action

None

Biological functions

None known; does not have described biological functions itself. The active parent molecule, U6 snRNA, is involved in spliceosome assembly for pre-mRNA splicing[5][13].Pseudogenes can sometimes exert indirect regulatory effects (such as competitive endogenous RNA activity), but there is no specific evidence for RNU6-289P[4].

Disease associations

None known; not implicated in any disease or pathology. Some other snRNA pseudogenes have been reported to correlate with disease, but RNU6-289P is not documented as such[2][7].

Beyond the preview

Go deeper on RNA, U6 small nuclear 289, pseudogene (RNU6-289P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 289, pseudogene (RNU6-289P).

Explore the full profile